These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2354118)

  • 1. Cyclosporin A levels in suction-blister fluid of patients with psoriasis treated systemically.
    Meinardi MM; Van Eendenburg JP; Oosting J; Van Boxtel CJ; De Rie MA; Bos JD
    Br J Dermatol; 1990 May; 122(5):671-6. PubMed ID: 2354118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of cyclosporin A level for efficacy or renal dysfunction in psoriasis.
    Feutren G; Friend D; Timonen P; Barnes A; Laburte C
    Br J Dermatol; 1990 Jun; 122 Suppl 36():85-93. PubMed ID: 2369572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of hyaluronate in suction blister fluid from active psoriatic lesions.
    Lundin A; Engström-Laurent A; Michaëlsson G; Tengblad A
    Br J Dermatol; 1987 Mar; 116(3):335-40. PubMed ID: 3567072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
    Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of psoriasis with cyclosporin A--side-effects, minimal effective dose and cyclosporin blood levels.
    Korstanje MJ; Van de Staak WJ
    Clin Exp Dermatol; 1991 Jan; 16(1):8-10. PubMed ID: 1902760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD14 monocyte antigen in suction blister fluid and serum of patients with psoriasis.
    Schopf RE; Dobmeyer J; Dobmeyer T; Morsches B
    Dermatology; 1993; 186(1):45-9. PubMed ID: 7679593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of 8-methoxypsoralen levels in plasma and skin suction blister fluid by a new sensitive fluorodensitometric method.
    Korting HC; Schäfer-Korting M; Roser-Maass E; Mutschler E
    Arch Dermatol Res; 1982; 272(1-2):9-20. PubMed ID: 7165325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.
    Schäfer-Korting M; Korting HC; Mutschler E
    Eur J Clin Pharmacol; 1985; 29(1):109-13. PubMed ID: 4054199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenced of food on the kinetics of 8-methoxypsoralen in serum and suction blister fluid in psoriatic patients.
    Herfst MJ; De Wolff FA
    Eur J Clin Pharmacol; 1982; 23(1):75-80. PubMed ID: 7128674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of side-effects of medium- and low-dose cyclosporin maintenance therapy in psoriasis.
    de Rie MA; Meinardi MM; Bos JD
    Br J Dermatol; 1990 Sep; 123(3):347-53. PubMed ID: 2206973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose cyclosporin A in severe psoriasis. A double-blind study.
    Van Joost T; Bos JD; Heule F; Meinardi MM
    Br J Dermatol; 1988 Feb; 118(2):183-90. PubMed ID: 3280000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suction blister fluid as a model for interstitial fluid in rats.
    Herfst MJ; van Rees H
    Arch Dermatol Res; 1978 Dec; 263(3):325-4. PubMed ID: 742910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythromycin ethyl succinate: diffusion through interstitial dermal fluid.
    Vaillant L; Lorette G; Loulergue J; Audurier A
    Eur J Clin Pharmacol; 1987; 33(5):529-30. PubMed ID: 3501376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term use of cyclosporin A in severe psoriasis.
    Van Joost T; Heule F; Stolz E; Beukers R
    Br J Dermatol; 1986 May; 114(5):615-20. PubMed ID: 3718852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Goeckerman therapy on interferon in serum and suction blister fluid from patients with psoriasis.
    Livden JK; Bjerke JR; Degre M; Matre R
    Br J Dermatol; 1986 Feb; 114(2):217-25. PubMed ID: 2418865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin level is significantly elevated in lesional skin of patients with psoriasis.
    El-Khateeb EA; Zuel-Fakkar NM; Eid SM; Abdul-Wahab SE
    Int J Dermatol; 2011 Jun; 50(6):693-6. PubMed ID: 21595663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four years of experience with cyclosporin A for psoriasis.
    Powles AV; Baker BS; Valdimarsson H; Hulme B; Fry L
    Br J Dermatol; 1990 Jun; 122 Suppl 36():13-9. PubMed ID: 2369568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of cyclosporin A in psoriasis: a summary of the United States' experience.
    Fradin MS; Ellis CN; Voorhees JJ
    Br J Dermatol; 1990 Jun; 122 Suppl 36():21-5. PubMed ID: 2196080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration.
    Schäfer-Korting M; Korting HC; Lukacs A; Heykants J; Behrendt H
    J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):211-5. PubMed ID: 2155951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of plasma prekallikrein levels in human skin blister and chamber fluids from volunteer subjects and psoriatic patients.
    Thomas NK; Marshman G; Worthy K; Burton J; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 3)():397-404. PubMed ID: 1462873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.